Сортировать:
- по релевантности
- по дате
- по зарплате
... as well as branches in the USA, Germany, Turkey, Saudi Arabia, and the UAE. R-Pharm Holding generates over $2 billion in revenue and employs more than 5,000 staff. Olokizumab is the first interleukin-6 (IL-6) inhibitor approved for treatment of rheumatoid ...
25.12.2025